11 research outputs found
Additional file 1: of Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1ÃŽÄ…/VEGFA signalling in hepatocellular carcinoma
Table S1. Sequences of primers and probe sequences used in this study. (DOC 14 kb
Additional file 2: of Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1ÃŽÄ…/VEGFA signalling in hepatocellular carcinoma
Figure S1. (A) The infection efficiencies of lncRNA UBE2CP3 in HepG2 and SMMC-7721 were screened by qRT-PCR. (B) The schematic diagram for the co-culture system. (C) 12 kinds of common angiogenic factors were detected by qRT-PCR.. (TIF 24 kb
Additional file 7: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Figure S2. Functions of the differentially expressed genes in glucose and glycogen metabolism. These genes included HK2, PDP2, G6PD, PGK1, PHKA1, PYGL, PDK1, and PKM2. (TIF 1108 kb
Additional file 8: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Figure S3. The pairwise comparison matrix used in the AHP model. The weighting coefficients of the criteria layer were calculated on the basis of the maximum eigenvalue using the sum-product method. (TIF 481 kb
Additional file 3: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Determination of the positive standard for CTCs counting. (DOCX 133 kb
Additional file 6: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Table S4. Gene information on the Human Glucose Metabolism Array. (DOCX 19 kb
Additional file 2: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Table S2. Antibodies used in Western blot analysis. (DOCX 21 kb
Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and statistical comparison between PC-3 M 2B4 and PC-3 M 1E8 cells in wound healing (A, 100×) and Transwell (B, 200×) assays. (C–D) Representative images and statistical comparison among LNCAP, PC-3, and DU145 cells by wound healing (C, 100×) and Transwell (D, 200×) assays. ***P < 0.001; Scale bar = 150 μm. (TIF 19013 kb
Additional file 11: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Table S7. Metabolic and EMT subtypes of CTCs in non-metastatic and metastatic PCa patients (Cohort 2). (DOCX 24 kb
Additional file 1: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Table S1. Primer sequences for qRT-PCR. (DOCX 20 kb